Tag: GIS
Recent Post
Marker Therapeutics Inc. (NASDAQ: MRKR) Receives FD Approval For MT-601 IND...
Marker Therapeutics Inc. (NASDAQ: MRKR) has announced that the US FD has approved its Investigational New Drug application for MT -601 for treatment of...